Degenerative lumbar spine disease Degenerative lumbar spine disease
Conditions
Interventions
Bupivacaine and nss soak of gel foam,Bupivacaine and nss and dynastat soak of gel foam
Experimental Drug,Active Comparator Drug
Sponsors
Buddhachinaraj hospital
Dynastat
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Degenerative lumbar spine disease Age > 18 years old No DM, autoimmune disease
Exclusion criteria
Exclusion criteria: Not degenerative lumbar spine disease Age< 18 years old U/d: DM, autoimmune disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale 8,24,48 ht postop post operative time | — |
Secondary
| Measure | Time frame |
|---|---|
| morphine comsumptiom 8,24,48 hr postop amount of morphine | — |
Countries
Thailand
Contacts
Public ContactSatawat Jirapan
Buddhachinaraj hospital
Outcome results
None listed